Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2011

View Archived Issues

Korean scientists synthesize novel protein kinase inhibitors

Phase II trial of antisense drug iCo-007 begins in the U.S.

Public gene expression data used to reposition drugs for new indications

SRT-1720 has beneficial effects in obesity model

New genetic variants in multiple sclerosis identified

Advinus Therapeutics discloses novel glucokinase activators

New immunosuppressants disclosed by Daiichi Sankyo

Chinese researchers patent novel anticancer agents

Pfizer synthesizes novel tyrosine-protein kinase inhibitors

Australian research team patents novel agents for RSV infection

Vertex designs novel series of protein kinase inhibitors

Fresolimumab receives orphan drug designation in the E.U.

Delcath reports data from phase II trial of its chemosaturation system

Isconova announces expansion of vaccine collaboration with Genocea

Cell Therapeutics submits response to questions raised by EMA regarding pixantrone MAA

Mesoblast performs first lumbar disc procedure in phase II stem cell trial

Incivek obtains approval in Canada for hepatitis C

Mayo Clinic obtains IND clearance for ovarian and breast cancer vaccine trials

First patient enrolled in phase I/II study of Hemispherx's Ampligen in breast cancer

Symphogen begins phase II trial of Sym-004 in head and neck cancer

AstraZeneca launches Brilinta in the U.S. for patients with ACS

Bayer gains FDA fast track designation for Alpharadin

Nippon Kayaku files for approval of additional dosages and indications for Randa and Lastet in Japan

BioDelivery Sciences plans commercial launch of Onsolis in Canada

Cres Pharmaceuticals compound obtains orphan status for primary myelofibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...